Shattuck Labs, Inc. (STTK)
STTK Stock Price Chart
Explore Shattuck Labs, Inc. interactive price chart. Choose custom timeframes to analyze STTK price movements and trends.
STTK Company Profile
Discover essential business fundamentals and corporate details for Shattuck Labs, Inc. (STTK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
9 Oct 2020
Employees
44.00
Website
https://www.shattucklabs.comCEO
Taylor H. Schreiber
Description
Shattuck Labs, Inc. operates as a biotechnology firm based in the United States, currently at the clinical development stage. Its core mission is to create innovative therapeutics designed to combat both cancer and autoimmune diseases. The company's leading experimental compound, SL-172154, is presently undergoing Phase 1 clinical assessment for the treatment of ovarian, fallopian tube, and peritoneal cancers. Furthermore, Shattuck Labs is advancing another product candidate, SL-279252, which is also in Phase 1 trials for patients afflicted with advanced solid tumors and lymphoma. Established in 2016, the company maintains its corporate headquarters in Austin, Texas.
STTK Financial Timeline
Browse a chronological timeline of Shattuck Labs, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Aug 2026
EPS estimate is -$0.15.
Earnings released on 7 May 2026
EPS came in at -$0.13 surpassing the estimated -$0.14 by +7.14%.
Earnings released on 5 Mar 2026
EPS came in at -$0.12 matching the estimated -$0.12.
Earnings released on 6 Nov 2025
EPS came in at -$0.14 surpassing the estimated -$0.15 by +6.67%, while revenue for the quarter reached $1.00m , beating expectations by +499.99%.
Earnings released on 14 Aug 2025
EPS came in at -$0.24 surpassing the estimated -$0.25 by +4.00%.
Earnings released on 1 May 2025
EPS came in at -$0.27 surpassing the estimated -$0.29 by +6.90%.
Earnings released on 27 Mar 2025
EPS came in at -$0.37 surpassing the estimated -$0.38 by +2.63%, while revenue for the quarter reached $14.49m , beating expectations by +1.71k%.
Earnings released on 14 Nov 2024
EPS came in at -$0.33 surpassing the estimated -$0.41 by +19.51%, while revenue for the quarter reached $3.00m , beating expectations by +1.10k%.
Earnings released on 1 Aug 2024
EPS came in at -$0.42 falling short of the estimated -$0.41 by -2.44%, while revenue for the quarter reached $1.61m , beating expectations by +177.41%.
Earnings released on 2 May 2024
EPS came in at -$0.37 surpassing the estimated -$0.47 by +21.28%, while revenue for the quarter reached $1.12m , beating expectations by +265.97%.
Earnings released on 29 Feb 2024
EPS came in at -$0.41 surpassing the estimated -$0.51 by +19.61%, while revenue for the quarter reached $714.00k , beating expectations by +257.00%.
Earnings released on 9 Nov 2023
EPS came in at -$0.65 falling short of the estimated -$0.52 by -25.00%, while revenue for the quarter reached $686.00k , beating expectations by +281.11%.
Earnings released on 10 Aug 2023
EPS came in at -$0.50 surpassing the estimated -$0.52 by +3.85%, while revenue for the quarter reached $200.00k , beating expectations by +100.00%.
Earnings released on 9 May 2023
EPS came in at -$0.49 surpassing the estimated -$0.61 by +19.67%, while revenue for the quarter reached $57.00k , missing expectations by -28.75%.
Earnings released on 23 Feb 2023
EPS came in at -$0.60 surpassing the estimated -$0.62 by +3.23%, while revenue for the quarter reached $390.00k , beating expectations by +766.67%.
Earnings released on 8 Nov 2022
EPS came in at -$0.58 surpassing the estimated -$0.68 by +14.71%, while revenue for the quarter reached $212.00k .
Earnings released on 11 Aug 2022
EPS came in at -$0.65 falling short of the estimated -$0.61 by -6.56%, while revenue for the quarter reached $50.00k .
Earnings released on 12 May 2022
EPS came in at -$0.58 falling short of the estimated -$0.55 by -5.45%.
Earnings released on 15 Mar 2022
EPS came in at $0.18 surpassing the estimated -$0.43 by +141.86%, while revenue for the quarter reached $30.08m , beating expectations by +1.42k%.
Earnings released on 9 Nov 2021
EPS came in at -$0.41 surpassing the estimated -$0.44 by +6.82%, while revenue for the quarter reached $1.90m , missing expectations by -2.56%.
Earnings released on 11 Aug 2021
EPS came in at -$0.56 falling short of the estimated -$0.34 by -64.71%, while revenue for the quarter reached -$4.23m , missing expectations by -14.48%.
STTK Stock Performance
Access detailed STTK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
